trial · primary record
HL40626S tablets
Skin Disease
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 64 |
| Primary completion | 2027-05 |
| Primary endpoint | Parts 1 (SAD) and 2 (MAD): Incidence of Treatment-Emergent Adverse Events [Safety and Tolerability] |
| Registry ID | NCT07736586 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:31:55.306Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07736586
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.